Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company
What is the estimated market size of the Infusion Therapy Devices Market by the end of 2030?
The infusion therapy devices market has seen substantial growth recently. It is forecast to expand from $13.33 billion in 2025 to $14.74 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.5%. The market’s past development can be linked to the rising occurrence of chronic illnesses, an increase in hospital admissions needing infusion therapy, the broadening of oncology and diabetes treatments, greater adoption of intravenous drug delivery, and enhanced availability of infusion devices.
The infusion therapy devices market is projected to experience significant expansion over the coming years. This market is anticipated to reach $21.82 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.3%. Factors contributing to this growth during the projected period include the escalating demand for home healthcare services, the increased uptake of connected medical devices, the broadening scope of personalized medicine delivery, an intensified focus on minimizing medication errors, and greater investments in smart hospital infrastructure. Key trends expected in the forecast timeframe encompass the expanding use of smart infusion pumps, a growing need for portable and ambulatory infusion devices, the increased integration of dose error reduction systems, the widening implementation of home-based infusion therapy, and a heightened emphasis on patient safety and monitoring.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20849&type=smp
What Drivers Are Shaping Future Opportunities In The Infusion Therapy Devices Market?
The escalating occurrence of chronic diseases is set to drive the growth of the infusion therapy devices market. Chronic diseases are characterized as long-term health conditions that persist for a year or more, demanding ongoing medical attention or restricting daily activities. The rising prevalence of these conditions can stem from factors such as poor lifestyle choices, sedentary habits, unhealthy diets, and environmental influences, as well as an increase in risk factors like obesity, smoking, and stress. Infusion therapy devices help manage chronic diseases by delivering medications and fluids precisely and controllably directly into the bloodstream, thus ensuring consistent and effective treatment for conditions including diabetes, autoimmune disorders, and cancer, which in turn improves patient outcomes, boosts convenience, and reduces the need for frequent hospital visits. For example, in January 2023, the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, projected that by 2050, the number of individuals aged 50 years and above with at least one chronic illness will increase by 99.5%, climbing from 71.522 million in 2020 to 142.66 million. Thus, the increasing prevalence of chronic diseases is propelling the expansion of the infusion therapy devices market.
Which Segment Groups Are Influencing The Infusion Therapy Devices Market?
The infusion therapy devices market covered in this report is segmented –
1) By Product: Infusion Pumps, Intravenous (Iv) Sets, Cannulas, Needleless Connectors
2) By Mobility: Portable Infusion Pumps, Stationary Pumps
3) By Application: Oncology, Diabetes, Pain Management, Other Applications
4) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Homecare, Other End-Users
Subsegments:
1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, Insulin Infusion Pumps
2) By Intravenous (IV) Sets: Standard IV Sets, Extension IV Sets, IV Administration Sets with Filters
3) By Cannulas: Peripheral Intravenous (PIV) Cannulas, Central Venous Cannulas, Butterfly Cannulas
4) By Needleless Connectors: Positive Pressure Needleless Connectors, Neutral Pressure Needleless Connectors, Negative Pressure Needleless Connectors
What Trends Are Projected To Support The Growth Of The Infusion Therapy Devices Market?
Key players in the infusion therapy devices market are concentrating on creating advanced solutions, including pressure-enabled drug delivery (PEDD) technology, to improve the treatment of liver and pancreatic tumors. Pressure-enabled drug delivery (PEDD) describes a drug delivery method that leverages pressure to boost the infusion of therapeutic agents into tissues or organs, especially in regions where traditional approaches might encounter difficulties. For example, in November 2024, TriSalus Life Sciences, a US-based medical technology company, introduced the TriNav LV Infusion System and TriGuide Guiding Catheters, thereby expanding its pressure-enabled drug delivery (PEDD) offerings to optimize therapeutic delivery, which broadens treatment options and could potentially enhance patient outcomes. The TriNav LV Infusion System provides distinct features like accommodating larger blood vessels (3.5 to 5.0 mm), thus extending the application of TriSalus’ Pressure-Enabled Drug Delivery (PEDD) technology to a wider range of patients. This introduction broadens PEDD device compatibility from 1.5 mm to 5.0 mm vessels, furnishing interventional radiologists with an increased array of treatment possibilities. TriGuide Guiding Catheters are characterized by a larger inner diameter, a lubricious lining, and a reverse curve design, facilitating easier femoral access and enhancing procedural efficiency. Initial users have reported a 97% satisfaction rate, underscoring the system’s efficacy and user-friendliness in oncology treatments.
Who Are The Prominent Global Companies Shaping The Infusion Therapy Devices Market Landscape?
Major companies operating in the infusion therapy devices market are Roche Holding AG, Fresenius Kabi AG, Medtronic plc, Medline Industries Inc., Baxter International Inc., Terumo Corporation, Mindray Medical International Limited, Nipro Corporation, ICU Medical Inc., Cook Medical, LivaNova PLC, Vygon S.A., AngioDynamics Inc., B. Braun Melsungen AG, Moog Medical Devices Group, Kangaroo, Vantage Medical Technologies, Alaris Medical Systems Inc., Smiths Medical, Teleflex Incorporated
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/infusion-therapy-devices-global-market-report
Which Region Currently Holds The Largest Share Of The Infusion Therapy Devices Market?
North America was the largest region in the infusion therapy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infusion therapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Infusion Therapy Devices Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=20849&type=smp
Browse Through More Reports Similar to the Global Infusion Therapy Devices Market 2026, By The Business Research Company
Cigarette Filters Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/cigarette-filters-global-market-report
Bag Filter Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/bag-filter-global-market-report
Filters Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/filters-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company